Drawing for INTERNATIONAL PHARMACEUTICAL INDUSTRY WEEK

USPTO serial 76287412

INTERNATIONAL PHARMACEUTICAL INDUSTRY WEEK

Reviewed by CopyMark Law Group

Reg. 2689533Status 710
Filing date
Status date
Registration date
Feb 18, 2003
Examiner
POWERS, ALEXANDER L
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INTERNATIONAL PHARMACEUTICAL INDUSTRY WEEK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Arranging and conducting trade shows and business conferences in the fields of research and development and manufacturing of prescriptive, over-the-counter, trial and experimental pharmaceuticals and chemicals for use thereinSECTION 8 - CANCELLEDApr 15, 2002

Related trademarks

CopyMark links this record to cited ยง2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2009C8..CANCELLED SEC. 8 (6-YR)โ€”
Apr 28, 2008CFITCASE FILE IN TICRSโ€”
Aug 10, 2005COARTEAS CHANGE OF OWNER ADDRESS RECEIVEDโ€”
Sep 24, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVEDโ€”
Feb 18, 2003R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Dec 13, 2002CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTERโ€”
Dec 13, 2002IUAAUSE AMENDMENT ACCEPTEDโ€”
Dec 13, 2002AUPCAMENDMENT TO USE PROCESSING COMPLETEโ€”
Dec 11, 2002CNEAEXAMINERS AMENDMENT MAILEDโ€”
Nov 27, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2002DOCKASSIGNED TO EXAMINERโ€”
Nov 14, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICEโ€”
Nov 14, 2002MAILPAPER RECEIVEDโ€”
Nov 11, 2002IUAFUSE AMENDMENT FILEDโ€”
Nov 4, 2002PETGPETITION TO REVIVE-GRANTEDโ€”
Sep 26, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICEโ€”
Sep 26, 2002MAILPAPER RECEIVEDโ€”
Sep 16, 2002PINMINCOMPLETE PETITION NOTICE MAILEDโ€”
Jun 17, 2002PETRPETITION TO REVIVE-RECEIVEDโ€”
Jun 17, 2002MAILPAPER RECEIVEDโ€”
Jun 6, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline โ€” usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 12, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2001CNEAEXAMINER'S AMENDMENT MAILEDโ€”
Sep 4, 2001DOCKASSIGNED TO EXAMINERโ€”

Frequently asked questions

Related guidance